Oncotarget

Research Papers:

LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma

Chun-Hua Wang, Min Li, Li-Li Liu, Ruo-Yao Zhou, Jia Fu, Chris Zhiyi Zhang _ and Jing-Ping Yun

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2015; 6:42118-42129. https://doi.org/10.18632/oncotarget.5967

Metrics: PDF 2041 views  |   HTML 2233 views  |   ?  


Abstract

Chun-Hua Wang1,2,*, Min Li1,2,*, Li-Li Liu1,2, Ruo-Yao Zhou3, Jia Fu1,2, Chris Zhiyi Zhang1,2, Jing-Ping Yun1,2

1Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China

2Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China

3Okemos High School, Okemos MI 48864, USA

*These authors have contributed equally to this work

Correspondence to:

Jing-Ping Yun, e-mail: [email protected]

Keywords: LRG1, prognosis, immunohistochemistry, hepatocellular carcinoma

Received: March 27, 2015     Accepted: October 09, 2015     Published: October 19, 2015

ABSTRACT

Leucine-rich-alpha-2-glycoprotein1 (LRG1) is a novel oncogene-associated protein which has been clarified vital to the progression of human cancers, but its role in hepatocellular carcinoma (HCC) remains unclear. Here, we showed that the expression of LRG1 was noticeably increased in HCC tissues, compared to the nontumorous tissues. High LRG1 expression was significantly associated with tumor size (P = 0.004), tumor differentiation (P = 0.010), TNM stage (P < 0.001) and vascular invasion (P = 0.019). Kaplan-Meier analysis showed that LRG1 expression was closely correlated to overall survival and disease-free survival in a training cohort of 474 patients with HCC. The correlation was further validated in an independent cohort of 303 HCC patients. The prognostic implication of LRG1 was confirmed by stratified survival analyses. Multivariate Cox regression model indicated LRG1 as an independent poor prognostic indicator for overall survival (Hazard ratio = 1.582, 95% confident interval: 1.345–1.862, P < 0.001) and disease-free survival (Hazard ratio = 1.280, 95% confident interval: 1.037–1.581, P = 0.022) in HCC. In vitro data showed that LRG1 markedly promoted cell migration but has no effect on cell proliferation. Collectively, our data show that LRG1 is markedly up-regulated and serves as an independent factor of poor outcomes in HCC. Our study therefore provides a promising biomarker for prognostic prediction in clinical management of HCC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 5967